Related Experiment Video
Updated: Oct 9, 2025

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Donor selection for multiorgan transplantation
Stephanie Hsiao1, Kiran K Khush
1Cardiovascular Medicine, Stanford University, Stanford, California, USA.
Insights
Selecting donors for multiorgan transplantation is complex. This review outlines donor criteria for heart-kidney, heart-lung, and heart-liver transplants, guiding selection for better outcomes.
Area of Science:
- Transplantation immunology
- Organ procurement
- Surgical outcomes
Background:
- Multiorgan transplantation is increasing.
- Limited guidance exists for donor selection in multiorgan procedures.
- Donor availability and short ischemic times are challenges.
Purpose of the Study:
- Review Organ Procurement and Transplantation Network (OPTN) policy for multiorgan allocation.
- Define ideal donor criteria for specific multiorgan transplant combinations.
- Provide a framework for donor selection in multiorgan transplantation.
Main Methods:
- Review of current OPTN policy.
- Analysis of ideal donor characteristics for heart-kidney, heart-lung, and heart-liver transplants.
- Synthesis of data on HLA matching and organ tolerance.
Main Results:
- Heart-kidney transplants require stringent HLA matching; virtual crossmatch and desensitization can reduce wait times.
- Ideal heart-lung donors are younger, tolerate HLA mismatch, and have no smoking history.
- Livers show tolerance to HLA mismatch and may offer immune protection in combined transplants.
Conclusions:
- Younger donor age, size matching, fewer comorbidities, and HLA compatibility are crucial for multiorgan transplant success.
- Donor selection criteria vary significantly by organ combination.
- Further research and standardized guidelines are needed for optimal donor selection.
Purpose Of Review:
There is limited data and guidance on donor selection for multiorgan transplantation. In this article, we review the current Organ Procurement and Transplantation Network policy on multiorgan allocation and the ideal donor criteria for each specific organ, in order to provide a framework to guide donor selection for various scenarios of multiorgan transplantation, including heart-kidney, heart-lung, heart-liver and heart-kidney-liver transplant procedures.
Recent Findings:
Combined heart-kidney transplantation is the most common multiorgan transplant procedure and requires the most stringent HLA matching to ensure optimal graft survival. Using the virtual crossmatch and desensitization therapies can shorten waitlist times without increasing posttransplant rejection or mortality rates. The ideal heart-lung donor tends to be younger than other multiorgan transplants, and more tolerant to HLA mismatch, but ideally requires donors with no prior history of smoking, a short period of time on mechanical ventilation, adequate oxygenation and absence of pulmonary infection. The ideal heart-liver donor is often driven by criteria specific to the donor heart. Finally, several observational studies suggest that livers are more tolerant to HLA mismatch than other organs, and offer some degree of immune protection in combined organ transplants.
Summary:
Multiorgan transplantation is a steadily growing field. The required short ischemic time for the donor heart is often the limiting factor, as well as the scarcity of appropriate donors available within geographical confines. In general, as with single organ transplantation, younger age, size matching, few medical comorbidities and HLA compatibility confer the best posttransplant outcomes.
More Related Videos
12:49Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure